Endostar Synergizes with Radiotherapy to Inhibit Angiogenesis of Cervical Cancer in a Subcutaneous Xenograft Mouse Model

Endostar Synergizes with Radiotherapy to Inhibit Angiogenesis of Cervical Cancer in a Subcutaneous Xenograft Mouse Model

Background: To investigate the synergic effect and underlying mechanism of Endostar, a recombinant human endostatin used for anti-angiogenesis, in radiotherapy for cervical cancer. Methods: The Cell Counting Kit-8 (CCK-8) assay and plate cloning experiment were first employed to analyze the prolifer...

Full description

Bibliographic Details
Main Authors: Zhonghua Xu, Xianying Zhao, Hang Shu, Weiwei Luo, Yaqing Dong, Lei Xu, Haochen Zhu, Qihong Zhao, Yin Lv
Format: Article
Language:English
Published: IMR Press 2022-08-01
Series:Frontiers in Bioscience-Landmark
Subjects:
recombinant human endostatin
endothelial cell
cervical cancer
radiotherapy
Online Access:https://www.imrpress.com/journal/FBL/27/8/10.31083/j.fbl2708238

Internet

https://www.imrpress.com/journal/FBL/27/8/10.31083/j.fbl2708238

Similar Items